25 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor
Chia Tai Tianqing Pharmaceutical Group
Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist
Suven Life Sciences
LRRK2 inhibitors and methods of making and using the same
Dana-Farber Cancer Institute
Covalent small molecule DCN1 inhibitors and therapeutic methods using the same
University of Michigan
Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1H-benzo[d]imidazol-2(3H)-ones.
King Fahd University of Petroleum & Minerals
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
Tolero Pharmaceuticals
New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
Alexandria University
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Government College University
Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors
Astrazeneca
Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
Schering-Plough Research Institute
Pharmacological characterization of KUR-1246, a selective uterine relaxant.
Kissei Pharmaceutical
2-cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives
Algiax Pharmaceuticals